Sun Pharma Medication Private Limited, a amalgamated private limited company, was established on 31 August 2012 in Mumbai, Maharashtra, India. Engaging in drug formulation & development within the pharma sector, it holds CIN: U74900MH2012PTC235231. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹20.00 Cr and a paid-up capital of ₹20.00 Cr.
Its leadership includes Sailesh Trambaklal Desai (Director), Dilip Shantilal Shanghvi (Director), Subhagmal Mohanchand Dadha (Additional Director). Past directors included Sudhir Vrundavandas Valia, Ishverdas Jayantilal Patwa. It is based at Acme Plaza, Andheri Kurla Road Andheri (East), Mumbai, Maharashtra, 400059.
U74900MH2012PTC235231
235231
31 August 2012
₹20.00 Cr
₹20.00 Cr
Roc Mumbai
Unlisted
Amalgamated
Explore comprehensive insights into Sun Pharma Medication Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Sailesh Trambaklal Desai | Director | 31 Aug 2012 | Current |
| Dilip Shantilal Shanghvi | Director | 31 Aug 2012 | Current |
| Subhagmal Mohanchand Dadha | Additional Director | 26 Jun 2013 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 01 Jul 2013 | Past |
| Pramod Abcsdd | Manager | - | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Enhance accessibility to Sun Pharma Medication's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
Unlock access to Sun Pharma Medication's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Sun Pharma Medication, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Sun Pharma Medication, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sun Pharma Medication's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Subhagmal Mohanchand Dadha was appointed as a Additional Director was appointed as a Additional Director on 26 Jun 2013 & has been associated with this company since 12 years 5 months . was documented.
Progress on Sailesh Trambaklal Desai was appointed as a Director was appointed as a Director on 31 Aug 2012 & has been associated with this company since 13 years 3 months . was documented.
Dilip Shantilal Shanghvi was appointed as a Director was appointed as a Director on 31 Aug 2012 & has been associated with this company since 13 years 3 months . was recorded as a recent event.
The activity Sun Pharma Medication Private Limited was registered on 31 Aug 2012 with Roc Mumbai & aged 13 years 3 months as per MCA records. was completed.
Sun Pharmaceutical Industries plans to acquire all outstanding shares of Taro Pharmaceutical Industries for $43 per share in cash, aiming to gain complete control over its subsidiary.
When you try to be fancy with your company name but end up just confusing everyone. #SunPharma #TooManyAcronyms #JustSaySun #PharmaLife.
The CIN of Sun Pharma Medication Private Limited is U74900MH2012PTC235231.
Sun Pharma Medication Private Limited is headquartered at Acme Plaza, Andheri Kurla Road Andheri (East), Mumbai, Maharashtra, 400059.
Sun Pharma Medication Private Limited was incorporated on 31 August 2012.
The current directors of Sun Pharma Medication Private Limited are
The primary industry of Sun Pharma Medication Private Limited is Pharma.
Sun Pharma Medication Private Limited is unlisted.
The authorized capital of Sun Pharma Medication Private Limited is ₹20.00 Cr, and the paid-up capital is ₹20.00 Cr.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX